Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
NOVel cheap and Abundant Materials for catalytic biomass conversion (NOVACAM)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Integration
Action type: Collaborative project
Countries involved: Netherlands,United Kingdom,Spain,United Kingdom
Call:  (FP7-NMP-2013-EU-Japan, 2013)
Start date: 2013-09-01
End date: 2017-02-28
Duration (months): 42.0
Total project cost (EUR): 2415573.2
EU funding (EUR): 1786842.0
Participants: 5
Project status: CLOSED

NOVACAM addresses the development of novel technology to enable the substitution of critical metals in industrial catalysts (call objective). The project will aim to develop catalysts using non-critical elements for the conversion of biomass to chemicals and fuels. Catalysts are one of the six major uses of critical metals that are produced as byproducts of mining of primary metals, e.g. platinum group metals and lanthanides. Many industrial heterogeneous catalysts have been developed empirically, such that the role of these critical metals in affecting catalyst performance is not clearly understood. NOVACAM will develop innovative catalysts by applying a “catalysis by design” approach, integrating the complete chain of knowledge from fundamental research to proof of concept. The prototype catalysts will be benchmarked against current catalyst technology. Industrial use of biomass is at an early stage and presents an opportunity to develop the next generation of cheap and abundant catalysts. The main objectives of the project are (i) to understand by a “catalysis by design” approach the requirements for inorganic catalyst systems to speed up elementary reaction steps and valorise biomass with a focus on conversion of cellulose into fuels and chemicals; (ii) using these nanoscale insights to develop novel catalysts based on abundant elements for the conversion of biomass and (iii) to develop three proof of concept studies at laboratory scale to convert cellulose/sugar feedstocks into fuels and chemicals - specific attention will be paid to catalyst robustness. In this way, the extensive knowledge base acquired in catalysis research will be employed to design novel inorganic catalytic systems. The project will be carried out with a partner consortium in Japan with complementary expertises in the field of innovative catalyst research. An industrial advisory committee will be integrated into the project in order to maximise exploitability of the project results.

Keywords: replacement critical metals,catalysis,chemical industry,biomass,cellulose,nanoscience,design,synthesis,characterisation,reactions
Nanotechnology based gas multispectral sensing system for environmental control and protection (IAQSENSE)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Nanosciences and Nanotechnologies
Action type: Collaborative project
Countries involved: France,France,France,France,Switzerland,Spain,Germany,Bulgaria,Bulgaria
Call:  (FP7-NMP-2013-SMALL-7, 2013)
Start date: 2013-09-01
End date: 2016-08-31
Duration (months): 36.0
Total project cost (EUR): 4941914.78
EU funding (EUR): 3497924.0
Participants: 10
Project status: CLOSED

IAQ is a crucial factor for human’s apperception. It is proven that air quality affects the health and the well-being of people. IAQSense focuses on R&D to develop a new nanotechnology based on innovative sensor system, miniaturized, low cost for mass produced sensors. The main technology innovation is based on surface ion mobility dynamics, it separates each gas component and its concentration like a mass spectrometer and allows high sensitivity fast multi-gas detection, in a way never seen before. IAQSense Project will characterize, monitor and improve IAQ in an innovative way. To enlarge the field of detection, the sensor system includes in total 3 patented technologies with biomolecule detection and security related nanotechnologies. IAQsense objectives are to develop sensor systems and reach TRL6, including all electronics, pattern detection firmware and validate these systems and their impact in real environments (building, health, hazards scenarios). Ability for mass production and low cost are mandatory requirements. Developments include integrated IC for real time gas pattern processing with special architecture for low power and energy management; test and validation; predictive numerical models; implementation into buildings; preparation for industrialization. IAQSense brings a unique solution for VOC sensing in a growing sensor market and is participating in the innovation and European competitiveness while providing a strategic contribution to the European industry. IAQSense will-provide a major step in analysis and control of IAQ on every place, home, office, vehicles, and contributes to the optimum reduction in energy consumption, finally, it will pave the way for integration into portable devices for the best of future applications in health and security. The consortium is composed of 4 SMEs, 3 industrial, 3 research institutes. The project will last 3 years and will deliver a complete sensor system.

Keywords: sensor,gas sensing,modelling,adsorption,integrated nano-sensor,iaq,security,environment,spectrometer,nanotechnology,cantilever,protection,multispectral
Development of an integrated approach based on validated and standardized methods to support the implementation of the EC recommendation for a definition of nanomaterial (NANODEFINE)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Nanosciences and Nanotechnologies
Action type: Collaborative project
Countries involved: Netherlands,European organisations area,Austria,Denmark,Germany,Switzerland,France,Germany,United Kingdom,Germany,Germany,Germany,Belgium,Italy,Spain,Germany,Germany,United Kingdom,Sweden,United Kingdom,Germany
Call:  (FP7-NMP-2013-LARGE-7, 2013)
Start date: 2013-11-01
End date: 2017-10-31
Duration (months): 48.0
Total project cost (EUR): 9344999.4
EU funding (EUR): 6999283.0
Participants: 30
Project status: CLOSED

Nanotechnology is a key enabling technology. Still existing uncertainties concerning EHS need to be addressed to explore the full potential of this new technology. One challenge consists in the development of methods that reliably identify, characterize and quantify nanomaterials (NM) both as substance and in various products and matrices. The European Commission has recently recommended a definition of NM as reference to determine whether an unknown material can be considered as 'nanomaterial' (2011/696/EU). The proposed NanoDefine project will explicitly address this question. A consortium of European top RTD performers, metrology institutes and nanomaterials and instrument manufacturers has been established to mobilize the critical mass of expertise required to support the implementation of the definition. Based on a comprehensive evaluation of existing methodologies and a rigorous intra-lab and inter-lab comparison, validated measurement methods and instruments will be developed that are robust, readily implementable, cost-effective and capable to reliably measure the size of particles in the range of 1–100 nm, with different shapes, coatings and for the widest possible range of materials, in various complex media and products. Case studies will assess their applicability for various sectors, including food/feed, cosmetics etc. One major outcome of the project will be the establishment of an integrated tiered approach including validated rapid screening methods (tier 1) and validated in depth methods (tier 2), with a user manual to guide end-users, such as manufacturers, regulatory bodies and contract laboratories, to implement the developed methodology. NanoDefine will be strongly linked to main standardization bodies, such as CEN, ISO and OECD, by actively participating in TCs and WGs, and by proposing specific ISO/CEN work items, to integrate the developed and validated methodology into the current standardization work.

Keywords: nanomaterials,physico-chemical characterisation,standardisation,validation
Nanotherapeutics to Treat Antibiotic Resistant Gram-Negative Pneumonia Infections (PNEUMONP)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Nanosciences and Nanotechnologies
Action type: Collaborative project
Countries involved: Spain,Netherlands,Germany,Germany,Spain,Netherlands,France,Netherlands,Denmark,Italy
Call:  (FP7-NMP-2013-LARGE-7, 2013)
Start date: 2014-01-01
End date: 2017-12-31
Duration (months): 48.0
Total project cost (EUR): 7510269.74
EU funding (EUR): 5682351.0
Participants: 11
Project status: CLOSED

The main objective of PneumoNP is the development of a theragnostic system for the treatment of lung Gram-negative bacterial infections. As a proof of concept PneumoNP will focus the attention on Klebsiella pneumoniae caused infections. A diagnostic kit will be developed to enable a rapid and precise identification of the bacteria strain causing the infection and avoid the use of wide spectrum antibiotics. For the treatment a nanotherapeutic based inhalable antibiotic will be developed. The therapeutic nanosystem will be based on a nanocarrier combined with an antimicrobial peptide. 3 different types of NCs will be tested with 2 AMPs to be able to obtain a novel effective inhalable antimicrobial NS. Nanotherapeutics offers many advantages in pulmonary drug-delivery, due to the huge surface area available in the lungs and their potential to achieve uniform distribution of drug dose among the alveoli. To improve this delivery to the lungs an aerosol system will also be developed. Due to the characteristics related to pulmonary delivery of NCs, topical and systemic bioavailabilities are envisaged. A diagnostic kit will be generated to monitor the efficacy and efficiency of the therapy. Once this treatment is proved to be effective, it could then be applied to any Gram-negative lung bacterial infection. The number of antibiotic resistant bacteria strains is increasing rapidly, new types of therapy are urgently required to avoid the use of standard antibiotics. Gram-negative bacteria that cause pneumonia are one of the main sources of nosocomial infections, mainly in people with a weakened immune system. Apart from pneumonia they can cause bacteremia and other infections. Early detection of the infection source combined with the development of appropriate and effective NSs to treat multi-drug resistant (MDR) bacteria caused infections will definitely radically improve the healing process of patients and avoid complications for people in hospital.

Keywords: nanotherapeutic,theragnosis,diagnostic kit,nanocarrier,antimicrobial peptide,inhalable antimicrobial nanosystem,gram-negative bacteria,klebsiella pneumoniae,active biomolecules
Indium replacement by single-walled carbon nanotube thin films (IRENA)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Integration
Action type: Collaborative project
Countries involved: Finland,Denmark,France
Call:  (FP7-NMP-2013-EU-Japan, 2013)
Start date: 2013-09-01
End date: 2017-02-28
Duration (months): 42.0
Total project cost (EUR): 2349301.0
EU funding (EUR): 1799648.0
Participants: 3
Project status: CLOSED

This project aims to develop high performance materials, i.e. both metallic and semiconducting single-walled carbon nanotube (SWCNT) thin films to completely eliminate the use of the critical metals in electron devices: i) Indium in transparent conducting films (TCF, indium oxide doped by tin, ITO) and ii) Indium and Gallium as semiconductor In–Ga–Zn–O (a-IGZO) in thin film field effect transistors (TFTs). The target values for fully flexible transparent electrodes based on SWCNT thin films are 10 ohms/sq at 90% transparency, i.e. comparable to ITO-on-glass, with the midterm milestone of 40 ohms/sq at 90% transparency. The applicability of the developed SWCNT films will be further demonstrated in the high-performance TFTs on flexible and transparent polymer (Ion >1mA/mm, Ion/Ioff >10^5) and in 48 zone capacitive SWCNT touch sensor. Because of the rich resource of carbon element, recycling is not needed and the film material supports the friendly environment approach. During the growth of SWCNTs common transition metal nanoparticles will be used as catalyst. Based on the fundamental understandings, the performance and reliability of SWCNT transparent conductors and TFTs will be improved in this project, so that they can be used in highly performing products in the long term, such as AMOLEDs and future flexible electron devices with very large commercial potential in future consumer electronics. The project contributes to reduce the European and Japanese electronics industry dependence on the indium resources as well as the cost of manufacturing. Industrial partners from both Japan and EU will be invited to join the dissemination meetings to learn about the project results. Thus the project contributes to increase the competitiveness of the industry, especially to the SME's developing novel flexible electronics products. Project involves 3 world class teams from both Europe and Japan, having complementary expertise in nanotube synthesis, thin film manufacturing and flexible device manufacturing, in addition to detailed modeling of nanotube growth and thin film charge transport processes. Active exchange of researchers (minimum of 12 person months from EU to Japan and vice versa) will deepen the EU-Japan collaboration.

Keywords: ito replacement,indium,gallium,single-walled carbon nanotube,transistor,touch sensor,transparent and flexible electronics
Intelligent materials for in-situ heart Valve tissue engineering (IMAVALVE)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Materials
Action type: Collaborative project
Countries involved: Netherlands,Switzerland,Germany,Germany
Call:  (FP7-NMP-2013-SME-7, 2013)
Start date: 2014-01-01
End date: 2017-12-31
Duration (months): 48.0
Total project cost (EUR): 7338397.58
EU funding (EUR): 5652133.0
Participants: 7
Project status: CLOSED

In situ tissue engineering using a biodegradable synthetic scaffold that recruits endogenous cells from the bloodstream is emerging as a promising technology to create living heart valves inside the human body having the potential to last a life-time: one valve for life. Compared to classical tissue engineered heart valves this new technology demonstrates off-the-shelf availability at substantially reduced cost. The current proposal aims to further develop the synthetic biomaterials needed for the in situ tissue engineering of heart valves, to process these materials into a functional heart valve scaffold, and to perform all the necessary pre-clinical experiments to enable first-in-man clinical application. A novel approach to the biodegradable scaffold will be developed, that combines a relatively slowly degrading (months) elastomeric material with a fast degrading (weeks) bioactive hydrogel material. These materials will be processed into a fibrous heart valve scaffold by means of electrospinning. The elastomeric material ensure long term functionality of the valve while supporting in-vivo mature tissue formation, while the fast eroding hydrogel material controls the early inflammatory response and creates the necessary void space between the elastomeric fibers. A minimally invasive, transapical, implantation technique will be used for the placement of the heart valve scaffold at the aortic position, following our recent results. For this purpose, tailor-made stents will be developed.

Keywords: bio-materials,biomedical tissue engineering,cardiovascular,heart valves,pre-clinical validation.
Rapid Prototyping of Custom-Made Bone-Forming Tissue Engineering Constructs. (RAPIDOS)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Materials
Action type: Collaborative project
Countries involved: Netherlands,Switzerland,United Kingdom,Netherlands
Call:  (FP7-NMP-2013-EU-China, 2013)
Start date: 2013-07-01
End date: 2017-06-30
Duration (months): 48.0
Total project cost (EUR): 2292156.0
EU funding (EUR): 1763251.0
Participants: 4
Project status: CLOSED

In cranio-maxillofacial surgery, large blow-out orbital floor fractures have still mitigated outcomes and improved scaffold solutions are needed. The reconstruction of large bone defects in proximal femur or proximal tibia in orthopaedic surgery is also an enormous challenge due to the requirements for both complex shape and partial load bearing ability. This is the goal of this European and Chinese consortium to apply technologies to create custom-made tissue engineered constructs made of resorbable polymer (PTMC or PLGA) and calcium phosphate ceramic composites specifically designed by integrating 1) imaging and information technologies, 2) biomaterials and process engineering, and 3) biological and biomedical engineering for novel and truly translational bone repair solutions. Advanced solid free form fabrication technologies; precise stereolithography and low melt temperature rapid prototyping will provide the necessary control to create such innovative high resolution medical devices. The use of Chinese Medicine extract, bone anabolic Icaritin which has shown to promote osteogenic differentiation of stem cells and enhance bone healing in vivo, will be a safe and technologically relevant alternative to the intensely debated growth factors. These challenges will advantageously be confronted by a strong Eastern -Western biomaterials collaborative effort. The synergistic collaboration envisioned will allow; 1) comparison and exchange of advanced and commercially relevant biomaterials developed; 2) parallel development of two precise technologies, stereolithography and low temperature rapid prototyping allowing for preparation of custom-made composite scaffolds loaded with unique biologics effectors. The planned personal exchanges, the scientific workshops, the use of a unique IT platform connecting trauma surgeons worldwide with the scientists of the consortium will insure that the flow of knowledge and exchange of exciting findings.

Keywords: bone clinical imaging precise and rapid prototyping stereolithography low temperature macro-structure calcium phosphate biodegradable polymers composite tissue engineering chinese medicine extract
Printed Logic for Applications of Screen Matrix Activation Systems (PLASMAS)

Framework: FP7 — Cooperation
Programme: Nanosciences, Nanotechnologies, Materials and new Production Technologies - NMP
Destination: Integration
Action type: Collaborative project
Countries involved: United Kingdom,Sweden,Germany,Germany,Cyprus,France,United Kingdom,Austria
Call:  (FP7-NMP-2013-SME-7, 2013)
Start date: 2013-11-01
End date: 2017-04-30
Duration (months): 42.0
Total project cost (EUR): 4801521.8
EU funding (EUR): 3635432.0
Participants: 12
Project status: CLOSED

The EU has lost a significant share of the electronics manufacture sector to the Far East, resulting in a negative trade balance of >€100bn/year within this sector. This is (in part) due to the current manufacturing technologies that are based on subtractive processing that are expensive, wasteful and energy intensive, making manufacture in the EU economically and environmentally unfeasible. Printed electronics is set to revolutionise the electronics industry by enabling direct, additive processing that significantly reduces capital and operating costs as well as massively reducing process hazardous chemical waste and energy. Currently the EU dominates the innovation and technological know-how in printed electronics. It is very important that this intellectual capital that Europe developed is translated to direct economic benefits by ensuring that manufacture is retained within the EU. However, there are barriers that are preventing widespread adoption of printed electronics including the availability of cost effective, high performance electronic inks, lack of awareness of end-users and lack of integration of individual printed components into large systems. PLASMAS directly builds on world-leading nano-materials, printing and display device technologies developed and patented by the consortium members. Our consortium is unique in that it covers the entire supply chain and also in terms of its ambition. PLASMAS directly addresses the current commercialisation barriers by demonstrating the capability of technology (based on novel copper and silicon inks with favourable cost to performance ratios) through development of printed circuit boards and printed logic as well as displays with printed copper and silicon-based back panels and established “self-emissive” OLEDs and “reflective” low power Electro-Chromic elements. As a consequence of the limitations in the availability of printed silicon an emphasis will be put on the development of printed grid electrodes for OLEDs and OPV applications as well as printed R2R fabricated RFID antenna structures. The addressing of EC displays will be accomplished by using ECT based technology. Thereby PLASMAS will make a significant step forward in commercialising these technologies and ensuring that the commercial benefits are maximised for the EU.

Keywords: electronic systems,electronic materials,nano-materials,nano-copper,nano-silicon,ink jet printing,large scale electronic applications,oleds,large area displays,ecds.